Skip to main navigation Skip to search Skip to main content

Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

  • Adrianna Murphy
  • , Benjamin Palafox
  • , Owen O'Donnell
  • , David Stuckler
  • , Pablo Perel
  • , Khalid F. AlHabib
  • , Alvaro Avezum
  • , Xiulin Bai
  • , Jephat Chifamba
  • , Clara K. Chow
  • , Daniel J. Corsi
  • , Gilles R. Dagenais
  • , Antonio L. Dans
  • , Rafael Diaz
  • , Ayse N. Erbakan
  • , Noorhassim Ismail
  • , Romaina Iqbal
  • , Roya Kelishadi
  • , Rasha Khatib
  • , Fernando Lanas
  • Scott A. Lear, Wei Li, Jia Liu, Patricio Lopez-Jaramillo, Viswanathan Mohan, Nahed Monsef, Prem K. Mony, Thandi Puoane, Sumathy Rangarajan, Annika Rosengren, Aletta E. Schutte, Mariz Sintaha, Koon K. Teo, Andreas Wielgosz, Karen Yeates, Lu Yin, Khalid Yusoff, Katarzyna Zatońska, Salim Yusuf, Martin McKee
  • London School of Hygiene and Tropical Medicine
  • Erasmus University Rotterdam
  • University of Lausanne
  • Bocconi University
  • King Saud University
  • Universidade de Santo Amaro
  • Chinese Academy of Medical Sciences
  • University of Zimbabwe
  • The George Institute for Global Health
  • University of Ottawa
  • Université Laval
  • University of the Philippines
  • Estudios Clinicos Latinoamerica ECLA
  • Nisa Hastanesi
  • Universiti Kebangsaan Malaysia
  • Aga Khan University
  • Isfahan University of Medical Sciences
  • Loyola University Chicago
  • Universidad de la Frontera
  • Simon Fraser University
  • Fundación Oftalmológica de Santander
  • Madras Medical College
  • St. John's National Academy of Health Sciences
  • University of the Western Cape
  • McMaster University
  • Sahlgrenska University Hospital
  • North West University
  • Independent University, Bangladesh
  • Queen's University Kingston
  • Universiti Teknologi MARA
  • Wrocław Medical University

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Abstract

Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals with self-reported cardiovascular disease from 21 countries enrolled in the Prospective Urban Rural Epidemiology (PURE) study. Defining one or more drugs as a minimal level of secondary prevention, wealth-related inequality was measured using the Wagstaff concentration index, scaled from −1 (pro-poor) to 1 (pro-rich), standardised by age and sex. Correlations between inequalities and national health-related indicators were estimated. Findings: The proportion of patients with cardiovascular disease on three medications ranged from 0% in South Africa (95% CI 0–1·7), Tanzania (0–3·6), and Zimbabwe (0–5·1), to 49·3% in Canada (44·4–54·3). Proportions receiving at least one drug varied from 2·0% (95% CI 0·5–6·9) in Tanzania to 91·4% (86·6–94·6) in Sweden. There was significant (p<0·05) pro-rich inequality in Saudi Arabia, China, Colombia, India, Pakistan, and Zimbabwe. Pro-poor distributions were observed in Sweden, Brazil, Chile, Poland, and the occupied Palestinian territory. The strongest predictors of inequality were public expenditure on health and overall use of secondary prevention medicines. Interpretation: Use of medication for secondary prevention of cardiovascular disease is alarmingly low. In many countries with the lowest use, pro-rich inequality is greatest. Policies associated with an equal or pro-poor distribution include free medications and community health programmes to support adherence to medications. Funding: Full funding sources listed at the end of the paper (see Acknowledgments).

Original languageEnglish
Pages (from-to)e292-e301
JournalThe Lancet Global Health
Volume6
Issue number3
DOIs
StatePublished - Mar 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 1 - No Poverty
    SDG 1 No Poverty
  2. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  3. SDG 8 - Decent Work and Economic Growth
    SDG 8 Decent Work and Economic Growth

Fingerprint

Dive into the research topics of 'Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study'. Together they form a unique fingerprint.

Cite this